• FirefoxInstall the new Firefox »
  •  Dow Down 0.58% Nasdaq Down 0.26%

    Curis, Inc. (CRIS)

    -NasdaqGM
    3.16 Up 0.01(0.32%) 4:00PM EST
    |After Hours : 3.16 Up 0.01 (0.32%) 4:04PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:3.15
    Open:3.14
    Bid:2.95 x 29000
    Ask:3.20 x 1000
    1y Target Est:5.00
    Beta:1.6
    Earnings Date:May 6 - May 11 (Est.)
    Day's Range:2.99 - 3.20
    52wk Range:1.09 - 3.50
    Volume:1,897,465
    Avg Vol (3m):1,402,850
    Market Cap:326.04M
    P/E (ttm):N/A
    EPS (ttm):-0.20
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    CRISUp 0.32%326.04M
    EXELUp 1.67%595.41M
    INFIUp 1.32%791.04M
    PFEUp 0.23%212.30B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):33.02
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.23
    Quarterly EPS Est (Mar-15) :-0.06
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Curis, Inc. is engaged in the research, development, and commercialization of cancer therapeutics. It focuses on developing cancer drug candidates, including CUDC-907, an oral, small molecule drug candidate that is designed to inhibit histone deac... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback